Ion Channels: Poring over furrows
Cryo-electron microscopy reveals the structure of a chloride channel that is closely related to a protein that transports lipids.
- Emory University School of Medicine, United States
Proteins known as calcium-activated chloride channels have a central role in processes as diverse as regulating blood pressure in mammals and closing the Venus flytrap (Hartzell et al., 2005). In 2008, it was discovered that the archetypal forms of these channels are encoded by a gene called TMEM16A (also known as ANO1; Caputo et al., 2008; Schroeder et al., 2008; Yang et al., 2008). Since this discovery, hundreds of papers have been published about these channels, providing important insights into the relationship between their structure and function. However, relatively little was known about the structure of the channels at the atomic level. Now, in eLife, Raimund Dutzler at the University of Zurich and colleagues – including Cristina Paulino as first author – report that they have used cryo-electron microscopy (cryo-EM) to obtain a near-atomic resolution structure of a mouse TMEM16A channel (Paulino et al., 2017).
The TMEM16 proteins are also known as anoctamins because it was first thought that all the proteins in the TMEM16A family contained eight (octa) transmembrane domains and had pores that allowed chloride ions and other anions to traverse membranes. However, the use of this name has been controversial because many of the TMEM16 proteins are not, in fact, anion channels, despite the similarity in their amino acid sequences. Rather, most of them are phospholipid scramblases that passively transport phospholipid molecules between the two lipid layers of cell membranes (Suzuki et al., 2010; Bevers and Williamson, 2016).
Phospholipids are amphipathic: they contain a hydrophilic ('water-loving') head attached to a hydrophobic ('water-hating') tail. When they assemble into membranes, the tails of the phospholipids in the outer layer orient towards the tails of the phospholipids in the inner layer so that the membrane has a hydrophobic core and hydrophilic surfaces. The Dutzler laboratory revealed how TMEM16 scramblases transport lipids between layers when they solved the X-ray structure of a fungal phospholipid scramblase known as nhTMEM16 (Brunner et al., 2014). This structure showed that these scramblases are made of pairs (dimers) of TMEM16 molecules. Each 'subunit' in the dimer has an unusual hydrophilic furrow on its surface that allows the heads of the phospholipids to move from one layer to the other while their tails remain in the hydrophobic core of the membrane.
The X-ray structure of nhTMEM16 sparked many questions about the differences between the structures of the scramblases and the ion channels. Unlike the scramblases, which transport amphipathic phospholipids, TMEM16A channels support the passage of small hydrophilic anions. It was initially hypothesized that TMEM16A subunits might form dimers with their hydrophilic grooves facing one another to create a single hydrophilic pore in the center (Brunner et al., 2014). However, this hypothesis was called into question by studies that demonstrated that TMEM16A dimers have two separate pores (Jeng et al., 2016; Lim et al., 2016). We suggested that the pore is composed of both proteins and lipids (Whitlock and Hartzell, 2016), but this model is now challenged by the new structure of mouse TMEM16A.
Paulino et al. now show that the mouse TMEM16A channel, like the nhTMEM16 scramblase, forms dimers with each subunit having 10 helices that span the membrane. Instead of being an open furrow, the ion-conducting pore in the channel is enclosed by protein along most of its length. This is due to a structural rearrangement that brings the two helices that form the edges of the furrow in nhTMEM16 together in TMEM16A to enclose the pore (Figure 1). The pore is shielded from the hydrophobic core of the membrane for about two-thirds the distance across the membrane while the remainder is open to the lipids and cytoplasm.
Figure 1
Comparison of a TMEM16 scramblase and a TMEM16 chloride channel.
The fungal nhTMEM16 protein (left), which acts as a lipid scramblase, and the mouse TMEM16A protein (right), which operates as a chloride ion channel, both contain 10 alpha helices (shown here as colored cylinders) embedded in the membrane. Only one subunit of the dimer is shown. The lower end of each protein faces into the cell, while the upper end faces outwards. While there are small differences in the relative locations of most of the helices, the biggest difference between the two proteins is the position of helix 4: in nhTMEM16 helix 4 is quite close to helix 3, which leads to the formation of a furrow by helices 4, 5 and 6; in TMEM16A helix 4 is further away from helix 3, and closer to helix 6, which leads to the formation of a narrow pore by helices 3–7. The furrow is able to transport lipids such as phosphatidylcholine (shown here), whereas the pore can transport chloride ions (pink sphere).
This model confirms the double-barreled nature of TMEM16A (Jeng et al., 2016; Lim et al., 2016): each subunit of the dimer has its own pore with the interface between the two formed largely by just one helix in each subunit. Confidence in the overall structural model is provided by experiments using mutagenesis to substitute positively charged amino acids in the pore with neutral ones. The effects of these substitutions are consistent with the idea that altering the charge of the pore will affect the ability of anions to move through the pore.
Several key questions remain. It is very likely that the TMEM16A structure described here is the conformation of the protein when it is bound to calcium ions because it was purified in the presence of high levels of calcium ions. However, it was not possible to determine the exact locations of individual amino acids within the pore, so the details of the geometry of the pore remain uncertain. Since TMEM16A readily inactivates in the presence of high levels of calcium ions (Lim et al., 2016), this structure could conceivably represent a state that does not conduct ions.
The narrowest part of the pore in the cryo-EM structure is estimated to be 3.6 angstroms wide, which is exactly the diameter of a chloride ion. This raises the question of how the pore could accommodate the passage of larger ions, such as iodide and tricyanomethanide, which are also known to be able to move through TMEM16A channels (Qu and Hartzell, 2000; Schroeder et al., 2008). In spite of this ambiguity, the findings of Paulino et al. are an essential step forward in understanding how chloride ions pass through TMEM16 channels and the evolutionary relationships between the members of this protein family.
References
-
Calcium-activated chloride channelsAnnual Review of Physiology 67:719–758.https://doi.org/10.1146/annurev.physiol.67.032003.154341
-
Independent activation of distinct pores in dimeric TMEM16A channelsThe Journal of General Physiology 148:393–404.https://doi.org/10.1085/jgp.201611651
-
Independent activation of ion conduction pores in the double-barreled calcium-activated chloride channel TMEM16AThe Journal of General Physiology 148:375–392.https://doi.org/10.1085/jgp.201611650
-
Anion permeation in Ca2+-activated Cl- channelsThe Journal of General Physiology 116:825–844.https://doi.org/10.1085/jgp.116.6.825
-
A pore Idea: the ion conduction pathway of TMEM16/ANO proteins is composed partly of lipidPflügers Archiv - European Journal of Physiology 468:455–473.https://doi.org/10.1007/s00424-015-1777-2
Article and author information
Author details
Publication history
Copyright
© 2017, Fisher et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,700
- views
-
- 146
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Ion Channels: Poring over furrows
eLife 6:e27933.
https://doi.org/10.7554/eLife.27933
Further reading
-
- Structural Biology and Molecular Biophysics
Previously, we reported that α-synuclein (α-syn) clusters synaptic vesicles (SV) Diao et al., 2013, and neutral phospholipid lysophosphatidylcholine (LPC) can mediate this clustering Lai et al., 2023. Meanwhile, post-translational modifications (PTMs) of α-syn such as acetylation and phosphorylation play important yet distinct roles in regulating α-syn conformation, membrane binding, and amyloid aggregation. However, how PTMs regulate α-syn function in presynaptic terminals remains unclear. Here, based on our previous findings, we further demonstrate that N-terminal acetylation, which occurs under physiological conditions and is irreversible in mammalian cells, significantly enhances the functional activity of α-syn in clustering SVs. Mechanistic studies reveal that this enhancement is caused by the N-acetylation-promoted insertion of α-syn’s N-terminus and increased intermolecular interactions on the LPC-containing membrane. N-acetylation in our work is shown to fine-tune the interaction between α-syn and LPC, mediating α-syn’s role in synaptic vesicle clustering.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
Inhibition of Bruton’s tyrosine kinase (BTK) has proven to be highly effective in the treatment of B-cell malignancies such as chronic lymphocytic leukemia (CLL), autoimmune disorders, and multiple sclerosis. Since the approval of the first BTK inhibitor (BTKi), Ibrutinib, several other inhibitors including Acalabrutinib, Zanubrutinib, Tirabrutinib, and Pirtobrutinib have been clinically approved. All are covalent active site inhibitors, with the exception of the reversible active site inhibitor Pirtobrutinib. The large number of available inhibitors for the BTK target creates challenges in choosing the most appropriate BTKi for treatment. Side-by-side comparisons in CLL have shown that different inhibitors may differ in their treatment efficacy. Moreover, the nature of the resistance mutations that arise in patients appears to depend on the specific BTKi administered. We have previously shown that Ibrutinib binding to the kinase active site causes unanticipated long-range effects on the global conformation of BTK (Joseph et al., 2020). Here, we show that binding of each of the five approved BTKi to the kinase active site brings about distinct allosteric changes that alter the conformational equilibrium of full-length BTK. Additionally, we provide an explanation for the resistance mutation bias observed in CLL patients treated with different BTKi and characterize the mechanism of action of two common resistance mutations: BTK T474I and L528W.
